NYZUMSA Trademark

Trademark Overview


On Wednesday, November 18, 2020, a trademark application was filed for NYZUMSA with the United States Patent and Trademark Office. The USPTO has given the NYZUMSA trademark a serial number of 79302146. The federal status of this trademark filing is IR CANCELLED - NO TRANSFORMATION FILED as of Friday, September 17, 2021. This trademark is owned by Glaxo Group Limited. The NYZUMSA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
nyzumsa

General Information


Serial Number79302146
Word MarkNYZUMSA
Filing DateWednesday, November 18, 2020
Status401 - IR CANCELLED - NO TRANSFORMATION FILED
Status DateFriday, September 17, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 8, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateSaturday, June 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Sunday, July 4, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Saturday, July 3, 2021DEATH OF INTERNATIONAL REGISTRATION
Tuesday, June 8, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 19, 2021NOTICE OF PUBLICATION
Friday, April 30, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 30, 2021ASSIGNED TO EXAMINER
Saturday, January 23, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, January 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 15, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, January 14, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB